Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Synapsin I ELISA Kit (AC3187)
Cat.#: ASET-1776
Specifications
Description Human Synapsin I ELISA Kit allows for the in vitro quantitative determination of human Synapsin I concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1023 Human ACTH ELISA Kit (AC2434) Quantitative inquiry ASET-1273 Mouse gamma MSH ELISA Kit (AC2684) Quantitative inquiry ASET-1458 Human Secretogranin 3 ELISA Kit (AC2869) Quantitative inquiry ASET-1627 Mouse AGRP ELISA Kit (AC3038) Quantitative inquiry ASET-1184 Rat Somatostatin ELISA Kit (AC2595) Quantitative inquiry ASET-1495 Mouse Dopamine Receptor D1 ELISA Kit (AC2906) Quantitative inquiry ASET-1009 Rat Apelin ELISA Kit (AC2420) Quantitative inquiry ASET-1901 Mouse CRMP2 ELISA Kit (AC3312) Quantitative inquiry ASET-1707 Porcine Obestatin ELISA Kit (AC3118) Quantitative inquiry ASET-1035 Mouse Adiponectin ELISA Kit (AC2446) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket